Last reviewed · How we verify

NCT05832294

Finding a Biomarker for Acute Neuromodulation Effects in Adolescent Depression

Status unknown NA Last updated 27 April 2023
What this trial tests

NA trial testing Treatment rTMS in Recruitment in 30 participants. Status unknown.

Timeline
20 April 2023
Primary endpoint
1 January 2025
1 January 2025

Quick facts

Lead sponsorSunnybrook Health Sciences Centre
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date20 April 2023
Primary completion1 January 2025
Estimated completion1 January 2025
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Sunnybrook Health Sciences Centre — full company profile →

Who can join

Adults 14 to 21, any sex, with Recruitment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot study aims to examine the feasibility of recruiting depressed adolescents to examine changes in emotional processing and in neural responses to emotional stimuli after one session of rTMS (which is followed by an open-label phase of 4 weeks active rTMS).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Recruitment

Currently open trials in the same condition.

Other Sunnybrook Health Sciences Centre trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05832294.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing